Biotin Injection 5ml:500μg

Biotin Injection 5ml:500μg | Vitamin B7 Supplement Injection
  • Dosage: Biotin 500μg
  • Volume:  5 ml per  Ampoule
  • Packaging: Sterile Ampoules for injection, 10 ampoules/tray*1 box
  • Shelf Life: 36 months 

Click to add this item to cart.

Product Description

Product NameBiotin Injection (Vitamin B7 / Vitamin H Injection)
Specification5mL:500μg (100μg/mL)
Dosage FormSterile, Nonpyrogenic Solution for Intravenous or Intramuscular Injection
Active IngredientBiotin (Vitamin B7 / Vitamin H)
Pharmacological ClassWater-Soluble Vitamin / B-Complex Vitamin / Carboxylase Cofactor
Route of AdministrationIntravenous injection (slow IV push) or intramuscular injection. May also be added to compatible infusion solutions for intravenous infusion.
Packaging5mL sterile glass ampoule or vial (with rubber stopper and aluminum seal)
StorageStore below 25°C, protected from light. Do not freeze. Keep ampoules/vials in outer carton until use.
Shelf Life36 months (unopened)

Product Overview

Biotin Injection 5mL:500μg is a sterile, nonpyrogenic solution of biotin (also known as vitamin B7 or vitamin H) intended for intravenous or intramuscular administration. Each 5mL ampoule or vial contains 500μg of biotin at a concentration of 100μg/mL. Biotin is a water-soluble B-complex vitamin that functions as an essential cofactor for four carboxylase enzymes involved in critical metabolic pathways. The parenteral formulation is designed for use in patients with biotin deficiency, multiple carboxylase deficiency (neonatal or late-onset biotinidase deficiency), and in patients receiving long-term parenteral nutrition who require supplemental biotin when oral administration is not feasible or adequate.

Biotin Injection 5ml:500μg: What the Published Guidance Says

Our largest functional group by product count — from the individual vitamins and minerals carried on the WHO Model List through to parenteral nutrition components and finished multivitamin presentations.

Biotin Injection 5ml:500μg sits in the Vitamins & Nutrition range. The notes below are the ones that most often change a specification, a label or a tender submission.

  • The Model List sections that carry this portfolio Vitamins and minerals sit in section 27 of the 24th WHO Model List (2025). The listings include ascorbic acid, cholecalciferol and ergocalciferol, iodine, nicotinamide, pyridoxine and retinol, alongside calcium and other minerals. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
  • Presentation matters as much as molecule An essential medicine is meant to be provided in an appropriate dosage form for the intended use and patient. A clinic that stocks the right molecule in an inappropriate presentation has met availability and missed usability — which is why we supply chewables, effervescents, drops, syrups and injectables across the same active ingredients. WHO — Essential medicines (fact sheet)
  • The economic case for essential medicines is documented WHO reports that medicines account for 20–60% of health spending in developing countries, with up to 90% of the population purchasing medicines through out-of-pocket payments, making medicines the largest family expenditure item after food. The 2025 Model List covers over 520 medicines, including 374 for children. WHO — Essential medicines (fact sheet)

Each point above is reproduced because it has a practical consequence for Biotin Injection 5ml:500μg: the strength you can register, the pack you can release, or the wording permitted on the label. Your national prescribing information always takes precedence.

Biotin Injection 5ml:500μg — Supply Parameters

Product NameBiotin Injection (Vitamin B7 / Vitamin H Injection)
Specification5mL:500μg (100μg/mL)
Dosage FormSterile, Nonpyrogenic Solution for Intravenous or Intramuscular Injection
Active IngredientBiotin (Vitamin B7 / Vitamin H)
Pharmacological ClassWater-Soluble Vitamin / B-Complex Vitamin / Carboxylase Cofactor
Route of AdministrationIntravenous injection (slow IV push) or intramuscular injection. May also be added to compatible infusion solutions for intravenous infusion.
StorageStore below 25°C, protected from light. Do not freeze. Keep ampoules/vials in outer carton until use.
Therapeutic groupVitamins & Nutrition — Vitamins & Nutrition
ManufacturerSinophare Bio-technology Co., Ltd. (GMP, China)
Documentation suppliedCOA, HPLC/GC data, stability data, dossier package

The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Alpha-Lipoic Acid Injection 5ml:125mg, L-Carnitine Injection 2ml:500mg, Pyridoxine Injection 1ml:100mg, Glutathione Injection 3000mg, Coenzyme Q10 Injection 2ml:5mg, Levocarnitine Injection 5ml:1000mg, Iron Sucrose Injection 5ml:100mg Ampoule, Vitamin B1 Injection 100mg/mL.

Quality Control, Pharmacopoeial Standards & Documentation

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Release testing for Biotin Injection 5ml:500μg follows the monograph you nominate — USP, EP, BP or CP. If the presentation is not covered by a monograph, the specification is frozen in writing with your quality team before the batch is manufactured.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

A typical release panel for this presentation covers:

  • Testing for heavy metals and elemental impurities
  • Testing for packaging integrity and seal testing
  • Testing for description and identification
  • Testing for assay of the active substance
  • Testing for related substances and impurities
  • Testing for dissolution or release profile (solid oral forms)

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

Packaging, Labelling & Export

  • Pack size: 5mL sterile glass ampoule or vial (with rubber stopper and aluminum seal). Non-standard pack sizes can be quoted against your artwork.
  • Storage: Store below 25°C, protected from light. Do not freeze. Keep ampoules/vials in outer carton until use..
  • Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
  • Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
  • Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.

Registration, Dossier & Tender Support

The legal manufacturer named on every document for Biotin Injection 5ml:500μg is Sinophare Bio-technology Co., Ltd., DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. The same entity appears on the GMP certificate and on the dossier submitted to your regulator.

  • Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
  • Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
  • Batch manufacturing and packaging records released for inspection on request during supplier audits.
  • Re-test or renewal support when the marketing authorisation comes up for variation or renewal.
  • CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.

Biotin Injection 5ml:500μg is presented here against vitamins, minerals and clinical nutrition products named in the WHO Model List. Inclusion in an essential-medicines list does not authorise sale in any particular country — the marketing authorisation for that market is a separate step.

Frequently Asked Questions

What pack size is available for Biotin Injection 5ml:500μg?

Standard commercial packaging for this line is 5mL sterile glass ampoule or vial (with rubber stopper and aluminum seal). Alternative pack sizes are produced to your specification and are supported by the corresponding stability data.

What documentation comes with a shipment of Biotin Injection 5ml:500μg?

The documentation set for every shipment includes the certificate of analysis (description, identification, assay, related substances), stability data for the marketed pack, and the site GMP certificate. Shelf life: 36 months.

Does the batch documentation for Biotin Injection 5ml:500μg support a registration filing?

The documentation set for every shipment includes the certificate of analysis (description, identification, assay, related substances), stability data for the marketed pack, and the site GMP certificate. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.

Which vitamins and minerals are on the WHO Model List?

Section 27 of the Model List carries minerals and vitamins including ascorbic acid, cholecalciferol and ergocalciferol, iodine, nicotinamide, pyridoxine and retinol. Ferrous salt with folic acid is listed as an antianaemia medicine.

Do you supply ferrous salt with folic acid?

Yes, in tablet form and in the strengths used by national anaemia-supplementation programmes. Confirm your programme's declared strength before ordering.

Related Vitamins & Nutrition Products

Browse the full Vitamins & Nutrition range; all Injectables; the complete product catalogue.

Request a Quotation for Biotin Injection 5ml:500μg

Tell us the monograph, pack size and quantity required for Biotin Injection 5ml:500μg 5mL, together with the destination market, and the quotation will state lead time and the documents that ship with the batch. Samples for registration can be added to the same order.

Request a quotation

Sources & Regulatory Notes

Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.

<< return to products